fbpx
All Day

HALO 2023 Q2

Halozyme Therapeutics (HALO) is expected to report qtrly profits (EPS) and revenues:

Profits Estimates: $0.50 vs. $0.47 = +6%
Revenue Est: +54%

Not a member? Sign up here for $25 a month.